[Antihypertensive agents and apoplexy].
Explore the source record for details and available documents.
Antihypertensive Agents↗
Biomedical subjects
Niels C Heebøll-Nielsen
Publications and source records attributed to Niels C Heebøll-Nielsen.
[Congress participation].
Explore the source record for details and available documents.
Congresses as Topic↗
[Statin--who can make out the prices?].
Explore the source record for details and available documents.
Anticholesteremic Agents↗
[Who is to be treated with statin?].
Explore the source record for details and available documents.
Anticholesteremic Agents↗
[Prevention of ischemic heart disease. Testing of three different methods for prediction of the risk of developing ischemic heart disease].
INTRODUCTION: The purpose of this evaluation was to compare estimation of risk of IHD, according to PRECARD and guidelines from DSAM and DCS. MATERIAL AND METHOD: The evaluation was performed in a general practice setting with relatively few elderly patients. Fifty consecutive patients were evaluated, 29 men and 21 women. Thirty-four patients were evaluated according to the physician's assessment and 16 according to the wishes of the patients. RESULTS: Four persons with definite ischaemic heart disease were included. According to DSAM, a further eight persons were found to have a > 20% risk of developing IHD. According to DCS, ten persons and to PRECARD three persons had a > 20% risk. DISCUSSION: Evaluation with PRECARD gives a more precise estimation than do DSAM and DCS. PRECARD uses the same risk factors as DSAM and DCS, but the HDL level and height/weight are also included. In addition, PRECARD estimates the risk of AMI, stroke, and fatal events, as well as the most important risk factors. PRECARD is recommended for use in general practice.
Adult↗